Possibility of treating basal cell carcinomas of nevoid basal cell carcinoma syndrome with superficial x-ray therapy

Dermatology

Volumn 208, Issue 1, 2004, Pages 60-63

  Caccialanza, Massimo ^a,b   Percivalle, Serena ^a   Piccinno, Roberta ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Basal cell carcinoma; Gorlin Goltz syndrome; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER RADIOTHERAPY; CANCER REGRESSION; CARCINOGENIC ACTIVITY; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; X RAY;

ADULT; AGED; BASAL CELL NEVUS SYNDROME; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; RADIATION DOSAGE; TREATMENT OUTCOME;

EID: 0942278974     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075048     Document Type: Article

References (29)

1. Anderson DE, Taylor WB, Falls HF, Davidson RT: The nevoid basal cell carcinoma syndrome. Am J Hum Genet 1967;19:12-22.
2. Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, Martin N, Wicking C, Chenevix-Tronch G: Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals. Am J Hum Genet 1994;50:282-290.
3. Evans DGR, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon PA: Complications of the naevoid basal cell carcinoma syndrome: Results of a population-based study. J Med Genet 1993;90:460-464.
4. Farndon PA, Del Mastro RG, Evans DGR, Kilpatrick MW: Location of gene for Gorlin syndrome. Lancet 1992;339:581-582.
5. Reis A, Kuster W, Linss G, Gebel E, Hamm H, Fuhrmann W, Wolff G, Groth W, Gustafson G, Kuklik M, Bürger J, Wegner R, Neitzel H: Localisation of gene for naevoid basal cell carcinoma syndrome. Lancet 1992;339:617.
6. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Togtgard R, Chenevix-Trench G, Wainwright B, Bale AE: Mutations of the human homolog of Drosophilapatchedin the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-851.
7. Johnson RL, Rothmann AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP: Human homolog ofpatched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-1671.
8. Honell JB, Caro MR: Basal cell nevus: Its relationship to multiple cutaneous cancers and associated anomalies of development. Arch Dermatol 1959;79:67-80.
9. Gorlin RJ, Vickers RA, Kelln E, Williamson JJ: The multiple basal-cell nevi syndrome: An analysis of a syndrome consisting of multiple nevoid basal cell carcinoma, jaw cysts, skeletal anomalies, medulloblastoma, and hyporesponsiveness to parathormone. Cancer 1965;18:89-104.
10. Gorlin RJ: Nevoid basal-cell carcinoma syndrome. Medicine 1987;66:98-113.
11. Mackie R: Epidermal skin tumours; in Champion RH, Burton JL, Burns DA, Breathnach SM (eds): Textbook of Dermatology, ed 6. Oxford, Blackwell Science, 1998, pp 1651-1693.
12. Strange PR, Lang PG: Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil. J Am Acad Dermatol 1992;27:842-845.
13. Cristofolini M, Zumiani G, Scappini P, Piscioli F: Aromatic retinoid in chemoprevention of the progression of nevoid basal cell carcinoma syndrome. J Dermatol Surg Oncol 1984;10: 778-781.
14. Goldberg LH, Hsu SH, Alcalay J: Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol 1989;21:144-145.
15. Sanchez Conejo-Mir J, Camacho F: Nevoid basal cell carcinoma syndrome: Combined etretinate and surgical treatment. J Dermatol Surg Oncol 1989;15:868-871.
16. Kopera D, Cerroni L, Fink-Puches R, Kerl H: Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol 1996;34:937-939.
17. Stockfleth E, Ulrich C, Hauschild A, Lischner S, Meyer T, Christophers E: Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 2002;12:569-572.
18. Schnyder UW: Vor- und Nachteile der Röntgenweichstrahltherapie der Basaliome. Ther Umsch 1976;33:524-528.
19. Martinez Escribano JA, Sanchez-Pedreno Guillen P, Delas Heras Gonzalez M, Sola Perez J, Frias Iniesta J: Sindrome de Gorlin: correlación entre la radioterapia y la expresión de la proteina p53 en los carcinomas basocellulares. Revisión de cinco casos. Med Cutan Iber Lat Am 1996;96:292-296.
20. Epstein E: Basal cell nevus syndrome; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds): Fitzpatrick's Dermatology in General Medicine, ed 6. New York, Mc Graw-Hill, 2003, pp 755-760.
21. Sobin H, Wittekind CH: TNM Classification of Malignant Tumours. New York, Wiley & Sons, 1997, pp 111-118.
22. Caccialanza M: Radiotherapy of neoplastic lesions of the eyelid. Ital Gen Rev Dermatol 1989;26:221-225.
23. Strong LC: Genetic and environmental interactions. Cancer 1977; 40(suppl 4):1861-1866.
24. Golitz LE, Norris DA, Lueckens CAS, Charles DM: Nevoid basal cell carcinoma syndrome. Arch Dermatol 1980;116:1159-1163.
25. Howell JR: Naevoid basal cell carcinoma syndrome: Profile of genetic and environmental factors in oncogenesis. J Am Acad Dermatol 1984;11:98-104.
26. Newton JA, Kobza Black A, Arlett CF, Cole J: Radiobiological studies in the naevoid basal cell carcinoma syndrome. Br J Dermatol 1990;123:573-580.
27. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK: p53 mutations in basal cell carcinoma. Cancer Res 1992;52:3804-3806.
28. Ling G, Ahmadian A, Persson A, Unden AB, Afink G, Williams C, Uhlen M, Toftgard R, Lundeberg J, Ponten F: Patched and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001;20:7770-7778.
29. O'Malley S, Weithan D, Olding M, Sekhar L: Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome: Case report. J Neurosurg 1997;86:286-288.